The University of Southampton
University of Southampton Institutional Repository

A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors

A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors
A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors
Background. There is concern that patients may be remaining on selective serotonin reuptake inhibitors (SSRIs) longer than is clinically indicated. Previous research has explored patients' experiences of taking SSRIs and decisions about starting medication. There has been less research into patients' reasons for long-term use and their views and experiences of discontinuation.

Aim. To explore patient experiences of and beliefs about their long-standing SSRI use and understand the barriers and facilitators to discontinuation.

Design. Face-to-face semi-structured qualitative interview study.

Setting. One group general practice in Southampton, UK.

Findings. Three overarching themes were identified: (i) patient uncertainty about the benefits of, and continued need for, SSRI medication; (ii) barriers to stopping, including fear of withdrawal symptoms and fear of relapse; and (iii) the importance of the GP's role in facilitating cessation. Uncertainty and fear about withdrawal symptoms and what patients would be like without their medication were key barriers to stopping, even among patients who felt no discernible benefit from taking SSRIs. Patients indicated a need to share the decision to stop with their GP. However, the majority of patients interviewed had received repeat prescriptions of SSRIs without being reviewed by the GP.

Conclusions. Patients prescribed SSRI medication need to be reassured that, as with starting medication, thinking about or actually stopping medication is a task that will not be managed in isolation, but with the support of their GP.
selective serotonin reuptake inhibitors, antidepressants, depression, discontinuation, patient management
0263-2136
570-575
Leydon, Geraldine M.
c5cdaff5-0fa1-4d38-b575-b97c2892ec40
Rodgers, Lynne
c697a72c-c698-469d-8ac2-f00df40583e5
Leydon, Geraldine M.
c5cdaff5-0fa1-4d38-b575-b97c2892ec40
Rodgers, Lynne
c697a72c-c698-469d-8ac2-f00df40583e5

Leydon, Geraldine M. and Rodgers, Lynne (2007) A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Family Practice, 24 (6), 570-575. (doi:10.1093/fampra/cmm069).

Record type: Article

Abstract

Background. There is concern that patients may be remaining on selective serotonin reuptake inhibitors (SSRIs) longer than is clinically indicated. Previous research has explored patients' experiences of taking SSRIs and decisions about starting medication. There has been less research into patients' reasons for long-term use and their views and experiences of discontinuation.

Aim. To explore patient experiences of and beliefs about their long-standing SSRI use and understand the barriers and facilitators to discontinuation.

Design. Face-to-face semi-structured qualitative interview study.

Setting. One group general practice in Southampton, UK.

Findings. Three overarching themes were identified: (i) patient uncertainty about the benefits of, and continued need for, SSRI medication; (ii) barriers to stopping, including fear of withdrawal symptoms and fear of relapse; and (iii) the importance of the GP's role in facilitating cessation. Uncertainty and fear about withdrawal symptoms and what patients would be like without their medication were key barriers to stopping, even among patients who felt no discernible benefit from taking SSRIs. Patients indicated a need to share the decision to stop with their GP. However, the majority of patients interviewed had received repeat prescriptions of SSRIs without being reviewed by the GP.

Conclusions. Patients prescribed SSRI medication need to be reassured that, as with starting medication, thinking about or actually stopping medication is a task that will not be managed in isolation, but with the support of their GP.

This record has no associated files available for download.

More information

Published date: 2007
Keywords: selective serotonin reuptake inhibitors, antidepressants, depression, discontinuation, patient management
Organisations: Primary Care & Population Sciences

Identifiers

Local EPrints ID: 61935
URI: http://eprints.soton.ac.uk/id/eprint/61935
ISSN: 0263-2136
PURE UUID: be3afebc-0faa-4d5f-8b91-6950a089c86b
ORCID for Geraldine M. Leydon: ORCID iD orcid.org/0000-0001-5986-3300
ORCID for Lynne Rodgers: ORCID iD orcid.org/0000-0003-1618-9381

Catalogue record

Date deposited: 08 Sep 2008
Last modified: 16 Mar 2024 03:45

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×